EA

Eassow Abraham Pullattu

Active Director Director DIN 09541874
DIN 09541874 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Eassow Abraham Pullattu

Data last updated:

Eassow Abraham Pullattu is a Director at Zellion Surgicals Private Limited (since 2022). The company operates in Healthcare.

DIN 09541874
Primary Designation Director
Industry Healthcare
First Appointment 21 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zellion Surgicals Private Limited U74999PN2022PTC209470
Director21 Mar 20222022Active

Board colleagues of Eassow Abraham Pullattu

NameDINCompanyDesignation
Monaz Firoz Amalsadwala07324874Zellion Surgicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zellion Surgicals Private Limited
Premium access

Shareholding and investment profile for Eassow Abraham Pullattu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eassow Abraham Pullattu

Eassow Abraham Pullattu currently holds 1 directorship: Zellion Surgicals Private Limited (Director, since 21 Mar 2022).

Eassow Abraham Pullattu was first appointed on 21 Mar 2022 as Director at Zellion Surgicals Private Limited.

The current boards of Eassow Abraham Pullattu's companies include Monaz Firoz Amalsadwala (Zellion Surgicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available